Cannabinoid Biosciences, Inc. Company Profile, Contacts & Intelligence

Cannabinoid Biosciences, Inc. Overview

Cannabinoid Biosciences, Inc. (“CBDZ”) is a biopharmaceutical company, which intends to engage in the discovery, development and commercialization of cures and novel therapeutics from proprietary cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids product platform suitable for specific treatments in a broad range of disease areas. Our business is divided into four segments namely: 1. Biopharmaceutical Research and Development; 2. Investments into legal-cannabis businesses and deriving value from rollup/consolidation events that leads to IPO in US or Canada; 3. Financial products in form of asset-backed loans, business property mortgages and other financial products to qualified individuals/businesses in the legal-cannabis businesses; and 4. Professional services including top-level financial reporting, Accounting Two of our business units are in flux and have investment opportunities that we want to capitalize upon immediately: • Rollup and Consolidation: Investments into legal-cannabis businesses and deriving value from rollup/consolidation events that leads to IPO in US or Canada; and • Financial products in form of asset-backed loans, business property mortgages and other financial products to qualified individuals/businesses in the legal-cannabis businesses. CBDZ is raising $125 million with Reg A+ ($50 million) and Reg. D 506 (c) ($75 million). The Company had filed the required filings with the SEC and is waiting for their go-ahead for the Reg. A+. CBDZ has agreed to rollup 10 dispensaries with $54 million in annual revenue. These rollup will IPO on the NASDAQ or NYSE and Canadian Securities Exchange (CSE) via Reg. A+, which is already filed with the SEC. Once our Reg A+ is qualified, CBDZ will be listed on the NASDAQ or NYSE. A $1,000 invested at this ground floor could fetch up to $21,500 based on what the NASDAQ and NYSE market-participants sale-to-market cap multiples for rollup/consolidated Cannabis business.

Headquarters

3699 Wilshire Blvd.

Website

cbdxfund.com

Industry

Biotechnology Research

Founded

2014

Stock Symbol

OR

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Cannabinoid Biosciences, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Cannabinoid Biosciences, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Cannabinoid Biosciences, Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Cannabinoid Biosciences, Inc.

Explore companies in related markets and compare their industry and employee estimates.